Login / Signup
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply.
Y Komaki
A Yamada
F Komaki
Atsushi Sakuraba
Published in:
Alimentary pharmacology & therapeutics (2017)
Keyphrases
</>
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
computed tomography
prognostic factors
peritoneal dialysis
magnetic resonance imaging
ulcerative colitis
image quality
positron emission tomography
patient reported
pet ct